Redmile Group, LLC - 16 May 2025 SCHEDULE 13D Report for Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
ATRA
Shares outstanding
7,123,303 shares
Disclosed Ownership
705,207 shares
Ownership
9.9%
Form type
SCHEDULE 13D
Filing time
23 May 2025, 16:05:24 UTC
Date of event
16 May 2025
Previous filing
15 May 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Quoteable Key Fact

"Redmile Group, LLC disclosed 9.9% ownership in Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA) on 16 May 2025."

Quick Takeaways

  • Redmile Group, LLC filed SCHEDULE 13D for Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA).
  • Disclosed ownership: 9.9%.
  • Date of event: 16 May 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 23 May 2025, 16:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 9.9% 705,207 0 705,207 /s/ Jeremy C. Green Managing Member 0001425738
Jeremy C. Green 9.9% 705,207 0 705,207 /s/ Jeremy C. Green Jeremy C. Green 0001650527
RedCo I, L.P. 5% 347,442 0 347,442 /s/ Jeremy C. Green Managing Member of RedCo I (GP), LLC, general partner of RedCo I, L.P 0001813157
Redmile Biopharma Investments II, L.P. 5.8% 406,137 0 406,137 /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments II (GP), LLC, general partner of Redmile Biopharma Investments II, L.P. 0001772230